Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Garzulys (insulin aspart-fsan)FDA approves Garzulys (insulin aspart-fsan)15 September 2026The FDA approved Garzulys (insulin aspart-fsan), a biologic from Emerge Bioscience Pte. Ltd.. Form: Vial, Multidose. Application BLA761497.FDA New Drug Approvals calendarMore from this calendar

20 October 2026 - FDA approves Hibsago (bepirovirsen)

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))